Skip to main content

Table 3 Clinical outcome of recipients based on type of donor

From: Living or deceased-donor kidney transplant: the role of psycho-socioeconomic factors and outcomes associated with each type of transplant

 

Living (n = 217)

Deceased (n = 199)

p-value‡

 

n (%)

n (%)

 

Medical events

  

.04

Acute Rejection

13(6)

17 (8.5)

.60

ATN

36 (16.6)

54 (27.13)

.03

DGF

43 (19.8)

68 (34.17)

.004

Arrhythmia

7 (3.22)

7 (3.5)

.97

Myocardial infarction

0 (0)

7 (3.5)

.02

Pulmonary emboli

3 (1.38)

3 (1.5)

.99

Infection

9 (4.15)

6 (3.01)

.82

Surgical events

  

.08

Hemorrhage

10 (4.6)

8 (4.02)

 

Vascular thrombosis

1 (0.46)

5 (2.51)

 

Ureteral complication

3 (1.38)

3 (1.5)

 

Surgical site infection

2 (0.92)

3 (1.5)

 

Lab Data

mean (SD)

Before Transplant→ After Transplant

Before Transplant→ After Transplant

p-value†

Hb

11.09 (2.28) → 10.05 (1.72)

11.54 (2.03) → 9.5 (1.49)

.04

WBC

10.40 (14.7) → 13.92 (13.20)

8.92 (7.26) → 10.39 (6.59)

.22

PLT

184.98 (61.8) → 189.61 (64.8)

196.95 (99.5) → 186.36 (66.0)

.15

AST

17.47 (9.11) → 26.60 (16.76)

20.04 (13.62) → 89.26 (7.65)

.03

ALT

19.22 (10.98) → 43.71 (49.43)

20.86 (18.40) → 40.91 (62.83)

.30

ALP

286.43(226.26) → 129.40 (16.67)

319.30 (237.57) → 131.38 (14.90)

.19

  1. ‡ Chi- square test
  2. † Paired t-test
  3. ESRD, end stage renal disease. ADPKD, autosomal dominant polycystic kidney disease. ATN, acute tubular necrosis. DGF, delayed graft function. Lab data, laboratory data. Hb, hemoglobin. WBC, white blood cell. PLT, platelet. AST, aspartate aminotransferase. ALT, alanine aminotransferase. ALP, alkaline phosphatase